WCLC 2025 - Posters & ePosters-EP.12.40 Clinical Efficacy and Safety Analysis of Osimertinib Versus Aumolertinib in Real-World Treatment of EGFRm Advanced NSCLC

EP.12.40 Clinical Efficacy and Safety Analysis of Osimertinib Versus Aumolertinib in Real-World Treatment of EGFRm Advanced NSCLC

Asset Subtitle

Hui Qiao

Meta Tag

Speaker Hui Qiao

Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy